Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Indomethacin + ibuprofen is a hypothetical combination of two nonsteroidal anti-inflammatory drugs (NSAIDs): indomethacin and ibuprofen. Both drugs act as inhibitors of cyclooxygenase (COX) enzymes, reducing the synthesis of prostaglandins involved in pain, inflammation, and fever. Indomethacin is typically used for moderate to severe pain associated with arthritis, bursitis, tendinitis, and gout[2][4][9]. Ibuprofen is commonly used for mild to moderate pain relief and inflammation in conditions such as osteoarthritis and rheumatoid arthritis[5]. Combining these two NSAIDs is not recommended due to a significantly increased risk of serious adverse effects such as gastrointestinal bleeding, ulceration, perforation, and other complications[2][3][6][7]. There are no approved pharmaceutical products or clinical guidelines supporting the use of this combination.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on indomethacin + ibuprofen.